Targeting iNKT cells for the treatment of sickle cell disease
- 31 August 2011
- journal article
- review article
- Published by Elsevier BV in Clinical Immunology
- Vol. 140 (2), 177-183
- https://doi.org/10.1016/j.clim.2011.03.002
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Adenosine A2A receptor activation on CD4+ T lymphocytes and neutrophils attenuates lung ischemia–reperfusion injuryThe Journal of Thoracic and Cardiovascular Surgery, 2010
- Adenosine A2A and A2B receptors work in concert to induce a strong protection against reperfusion injury in rat heartsJournal of Molecular and Cellular Cardiology, 2009
- Increased adenosine contributes to penile fibrosis, a dangerous feature of priapism, via A 2B adenosine receptor signalingThe FASEB Journal, 2009
- CD1-restricted adaptive immune responses to Mycobacteria in human group 1 CD1 transgenic miceThe Journal of Experimental Medicine, 2009
- Preactivation of NKT cells with α-GalCer protects against hepatic ischemia-reperfusion injury in mouse by a mechanism involving IL-13 and adenosine A2AreceptorAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2009
- Reduction in myocardial infarct size at 48 hours after brief intravenous infusion of ATL-146e, a highly selective adenosine A2A receptor agonistAmerican Journal of Physiology-Heart and Circulatory Physiology, 2009
- Cross‐regulation between distinct natural killer T cell subsets influences immune response to self and foreign antigensJournal of Cellular Physiology, 2008
- Selective activation, expansion, and monitoring of human iNKT cells with a monoclonal antibody specific for the TCR α‐chain CDR3 loopEuropean Journal of Immunology, 2008
- How dying cells alert the immune system to dangerNature Reviews Immunology, 2008
- Adenosine A2A receptor activation reduces hepatic ischemia reperfusion injury by inhibiting CD1d-dependent NKT cell activationThe Journal of Experimental Medicine, 2006